8-K
Current Report
Viridian Therapeutics, Inc.DE Filed Acc 0001590750-21-000013
Executive or director change · Bylaws or fiscal year change · Other events
- Item 5.02 Departure or appointment of directors or officers
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading vrdn-20210115.htm…